approval
saveBREXAFEMME (IBREXAFUNGERP CITRATE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) — FDA approvalNov 5, 2025
- approvalBUPROPION HYDROCHLORIDE: WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA approvalNov 5, 2025
- approvalVALACYCLOVIR HYDROCHLORIDE: VALTREX (VALACYCLOVIR HYDROCHLORIDE) — FDA approvalNov 12, 2025
- approvalbelantamab mafodotin: BLENREP (BELANTAMAB MAFODOTIN-BLMF) — FDA approvalOct 23, 2025
- approvalLAMOTRIGINE: LAMICTAL XR (LAMOTRIGINE) — FDA approvalOct 10, 2025
- approvalLAMOTRIGINE: LAMICTAL ODT (LAMOTRIGINE) — FDA approvalOct 10, 2025
comments(0)
5-min edit window · permanent after that